Ad is loading...
ADNRX vs PAMCX
ADNRX vs PAMCX Comparison
Open Charts ADNRX vs PAMCX
American Beacon ARK Transfmt Innov R6
Price$16.55
Change-$1.00 (-5.70%)
VolumeN/A
Net Assets195.39M
T. Rowe Price Mid-Cap Growth Adv
Price$93.50
Change-$1.97 (-2.06%)
VolumeN/A
Net Assets29.49B
ADNRX vs PAMCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
ADNRX vs. PAMCX commentary
Feb 23, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Hold and PAMCX is a Hold.
FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 29.5B vs. ADNRX (195M). ADNRX (0.00) and PAMCX (0.00) have matching dividends . ADNRX was incepted earlier than PAMCX: ADNRX (4 years) vs PAMCX (25 years). ADNRX is a more actively managed with annual turnover of: 33.00 vs. PAMCX (21.70). ADNRX has a lower initial minimum investment than PAMCX: ADNRX (0) vs PAMCX (2500). ADNRX annual gain was more profitable for investors over the last year : 24.91 vs. PAMCX (-6.10).
| ADNRX | PAMCX | ADNRX / PAMCX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 4 years | 25 years | - |
| Gain YTD | 6.158 | -0.490 | -1,258% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 195M | 29.5B | 1% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 24.91 | -6.10 | -409% |
| Returns for 3 years | -11.07 | -2.61 | 423% |
| Returns for 5 years | N/A | -1.26 | - |
| Returns for 10 years | N/A | 20.26 | - |